Pulmonary hypertension in autoimmune rheumatic diseases
- 20 December 2003
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 3 (4) , 313-320
- https://doi.org/10.1016/j.autrev.2003.11.004
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Angiopoietin-1 and Pulmonary HypertensionCirculation Research, 2003
- Angiogenesis and Pulmonary Hypertension: A Unique Process in a Unique DiseaseAntioxidants and Redox Signaling, 2002
- Pulmonary hypertension in autoimmune rheumatic diseases: Where are we now?Arthritis & Rheumatism, 2002
- Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertensionThe FASEB Journal, 2001
- Three-Dimensional Reconstruction of Pulmonary Arteries in Plexiform Pulmonary Hypertension Using Cell-Specific MarkersThe American Journal of Pathology, 1999
- Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension.Journal of Clinical Investigation, 1998
- Vascular Endothelial Growth Factor in Pulmonary HypertensionAnnals of the New York Academy of Sciences, 1996
- Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosusAmerican Heart Journal, 1995
- Clinical and pathologic manifestations of pulmonary vascular disease in the toxic oil syndromeJournal of the American College of Cardiology, 1991
- Primary Pulmonary Hypertension: A Histopathologic Study of 80 CasesMayo Clinic Proceedings, 1985